PDS Biotechnology Corp (PDSB) › Shareholders' EquityPDS Biotechnology Corp (PDSB) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2012: -$7.65M2013: -$15.35M2014: -$27.83M2015: $122.48M2016: $89.28M2017: -$609.5K2018: -$2.07M2019: $11.70M2020: $27.13M2021: $63.21M2022: $44.00M2023: $26.13M2024: $19.00M2025: $9.25M$9.25M2012Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$9.25M-51.3%2024$19.00M-27.3%2023$26.13M-40.6%2022$44.00M-30.4%2021$63.21M+133.0%2020$27.13M+131.9%2019$11.70M+666.1%2018-$2.07M-239.0%2017-$609.5K-100.7%2016$89.28M-27.1%2015$122.48M+540.0%2014-$27.83M-81.3%2013-$15.35M-100.6%2012-$7.65M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share